Rating Rationale
September 24, 2020 | Mumbai
Synthite Industries Private Limited
Long-term rating upgraded to 'CRISIL AA/Stable'; short-term rating reaffirmed
 
Rating Action
Total Bank Loan Facilities Rated Rs.740 Crore (Reduced from Rs.818 Crore)
Long Term Rating CRISIL AA/Stable (Upgraded from 'CRISIL AA-/Positive')
Short Term Rating CRISIL A1+ (Reaffirmed)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has upgraded its rating on the long-term bank facilities of Synthite Industries Private Limited (Synthite) to 'CRISIL AA/Stable' from 'CRISIL AA-/Positive', while reaffirming the rating on the short-term bank facilities at 'CRISIL A1+'. CRISIL has withdrawn its rating on bank loan facilities of Rs 78 crore following a request from the company and confirmation from the bank. The withdrawal is in line with CRISIL's rating-withdrawal policy.
 
The rating upgrade reflects sustained improvement in the business risk profile, backed by leadership in the spice oleoresin segment and continuous efforts to innovate and add new, value-added products. The business risk profile also benefits from the strong and longstanding relationship with customers.
 
Revenue increased at a healthy rate of around 15% in fiscal 2020 over the previous fiscal, while the operating margin was maintained at around 13%. The Covid-19 pandemic did not have much impact on operations both in terms of sourcing of inputs as well as supply. No significant sale orders were delayed or deferred. As a result, revenue is likely to grow by 8% in fiscal 2021.
 
Over the medium term, revenue is expected to grow by around 10% per fiscal, driven by sustained demand from existing customers and innovation in the bio-ingredients segment. The operating margin should also remain healthy at 12-14% aided by cost advantages emanating from efficient procurement of inputs and streamlining of production units. The company also faces minimal risk on account fluctuation in input price and foreign exchange (forex) rates, as inventory is backed by orders and receivables are completely hedged. Though operations will remain working capital intensive, improving cash accrual should ensure lower reliance on bank debt.
 
The financial risk profile improved in fiscal 2020 due to reduction in working capital borrowings following prudent inventory management and increase in cash accrual. With healthy accretion to reserves, modest capital expenditure (capex) plans and continued efficient working capital management, the gearing and debt protection metrics should remain healthy over the medium term. Liquidity is comfortable, aided by cash and cash equivalents of around Rs 60 crore as on March 31, 2020, and unutilised bank lines of around Rs 500 crore as on July 31st 2020.
 
The ratings continue to reflect an established brand, leading market position in the spice oils and oleoresins market in India, and a healthy financial risk profile. These rating strengths are partially offset by susceptibility to volatility in raw material prices and forex rates, and working capital-intensive operations.

Analytical Approach

CRISIL has combined the business and financial risk profiles of Synthite and its subsidiaries and joint-venture, due to operational and financial linkages. All the entities are together herein referred to as Synthite.

Please refer Annexure - List of entities consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description
Strengths:
* Leading exporter of spice oils and oleoresins with an established brand: Synthite is India's largest producer and exporter of spice oils and oleoresins. The company, which accounts for almost 50% of Indian exports of these commodities, derives 70-75% of revenue from the overseas market. It exports to more than 75 countries around the globe, lending considerable geographical diversity.
 
The company has longstanding relationships with leading food processing companies globally and a diverse client base as well. The top client contributes less than 10% of revenue, thereby mitigating client concentration risk. It has around 500 products and continues to invest in research and development to meet global quality standards and customise products as per client requirements..
 
* Healthy financial risk profile and liquidity: The gearing and debt protection metrics are comfortable. Reducing debt, and rising cash accrual improved the net cash accrual to total debt ratio to about 0.46 time in fiscal 2020, from 0.42 time in the previous fiscal. No substantial, debt-funded capex or acquisition is expected over the medium term. The capital structure is likely to remain comfortable, despite the working capital-intensive nature of operations. The networth was around Rs 1,400 crore as on March 31, 2020, and is expected to improve further, aided by steady cash generation.
 
Liquidity is supported by average unutilised bank lines of around Rs 450 crore in the 12 months through July 2020 and liquid funds of around Rs 60 crore as on March 31, 2020. The company also holds 6.5% of shares in Cochin International Airport Authority.
 
Weaknesses:
* Susceptibility to volatility in raw material prices and forex rates: Key raw materials are spices, such as pepper, chilli and turmeric, the prices of which have been volatile depending on supply level. While multiple procurement sources and the ability to pass on major increases in costs to customers mitigate this risk, any significant volatility in prices can impact margins. Also, despite the natural hedge available through input imports and product exports, and hedging undertaken on net exposure, any significant fluctuation in forex rates could impact the operating margin.
 
* Working capital-intensive operations: Due to seasonal procurement of raw materials, large inventory of 4-5 months is maintained; this is expected to continue with slight reduction due to better inventory management. Average gross current assets were around 270 days in the five fiscals ended March 31, 2020, and are expected to remain at a similar level over the medium term.
Liquidity Strong

Cash accrual of Rs 180-200 crore per fiscal in fiscals 2021 and 2022, and cash and cash equivalents of Rs 98 crore as on March 31, 2020, should comfortably cover capex, minimal maturing debt obligation and part of the incremental working capital requirement. The company is expected to invest around Rs 62 crore per fiscal (Rs 40 crore for expanding facilities and Rs 22 crore for maintenance capex) in fiscals 2021 and 2022. Average utilisation of the fund-based bank lines of Rs 745 crore was 27% during the 12 months through June 2020. With a gearing of about 0.27 time as on March 31, 2020, there is sufficient headroom to raise additional debt to fund capex, if required.

Outlook: Stable

CRISIL believes the business risk profile will remain stable over the medium term, backed by a healthy market position, pick-up in end-market demand and improving operating efficiency. The financial risk profile should remain healthy driven by healthy cash accrual, moderate capex plans and reducing reliance on bank borrowing for working capital funding.

Rating Sensitivity factors
Upward factors
* Sustained revenue growth of 20% per fiscal while maintaining a healthy operating margin of over 17%, resulting in significantly higher-than-expected cash accrual
* Sustenance of healthy credit metrics, with the gearing below 0.2 time and an increase in liquid surplus
 
Downward factors
* Significant decline in revenue by over 15% per fiscal and in the operating margin to below 10%, affecting cash accrual
* Large, debt-funded capex or acquisition, or a significant stretch in the working capital cycle, leading to weakening of key credit metrics
About the Company

Synthite, which was set up by Mr CV Jacob as Synthite Industrial Chemicals Ltd in 1972, commenced operations by manufacturing oleoresins from chosen Indian spices, such as pepper, turmeric and cardamom. It got its present name in September 2008. The company has subsidiaries in the US, Brazil, China, Vietnam and Sri Lanka. Subsidiaries in the US and Brazil act as marketing hubs, while the ones in Sri Lanka and Vietnam serve as procurement arms. The subsidiary at Dezhou, China, has a manufacturing setup and will be used both as a procurement arm and export unit.
 
Synthite offers over 500 products, including spice oleoresins, essential oils, floral concretes/absolutes, seasonings, resinoids (for the perfume industry), health and functional ingredients, and application-oriented, value-added products. The company has also diversified into other businesses, including realty and hospitality; however, these remain small relative to the large spice and spice-derivative business.

Key Financial Indicators - (Consolidated)
As on / for the period ended March 31   2019 2018
Revenue Rs crore 1482 1611
Profit after tax (PAT) Rs crore 103 113
PAT margin % 7.0 7.0
Adjusted debt/adjusted networth Times 0.29 0.48
Interest coverage Times 12.24 6.84

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments and are included (where applicable) in the Annexure -- Details of Instrument in this Rating Rationale. For more details on the CRISIL complexity levels, please visit www.crisil.com/complexity-levels.
Annexure - Details of Instrument(s)
ISIN Name of Instrument Date of Allotment Coupon Rate (%) Maturity Date Issue Size
(Rs Cr)
Complexity Level Rating Assigned
with Outlook
NA Cash Credit NA NA NA 0.2 NA CRISIL AA/Stable
NA Export Finance Limit^ NA NA NA 150 NA CRISIL A1+
NA Letter of Credit & Bank Guarantee NA NA NA 25 NA CRISIL A1+
NA Packing Credit## NA NA NA 159.8 NA CRISIL A1+
NA Packing Credit* NA NA NA 180 NA CRISIL AA/Stable
NA Packing Credit@@ NA NA NA 150 NA CRISIL A1+
NA Packing Credit NA NA NA 75 NA CRISIL A1+
NA Packing Credit NA NA NA 50 NA Withdrawn
NA Proposed Working Capital Facility NA NA NA 28 NA Withdrawn
^100% interchangeability between letter of credit
##100% interchangeability between packing credit in foreign currency, foreign documentary bill purchase, and foreign usance discount bill purchase
*100% interchangeability between packing credit in foreign currency, foreign bill purchase, foreign bill discounting, foreign bill negotiation, bill purchase, bill discounting, working capital demand loan, and short-term loan
@@100% interchangeability between packing credit in foreign currency, import letter of credit, standby letter of credit, short-term loan, and overdraft export invoice financing.
 
Annexure - List of entities consolidated
Names of entities Extent of consolidation Rationale for consolidation
Synthite (Xinjiang) Bio Tech Co Ltd Full Common management, similar line of business, business and financial linkages, and common promoters
Synthite (Beijing) Bio Tech Co Ltd Full Common management, similar line of business, business and financial linkages, and common promoters
Synthite (Dezhou) Bio Tech Co Ltd Full Common management, similar line of business, business and financial linkages, and common promoters
Synthite Brazil Importcao Exportcao Ltda Full Common management, similar line of business, business and financial linkages, and common promoters
Synthite USA Inc Full Common management, similar line of business, business and financial linkages, and common promoters
Synthite Lanka Private Limited Full Common management, similar line of business, business and financial linkages, and common promoters
Synthite Vietnam LLC Full Common management, similar line of business, business and financial linkages, and common promoters
Sijmak Exports Private Limited Full Common management, similar line of business, business and financial linkages, and common promoters
Algavista Greentech Private Limited Proportionate (50%) Common management, similar line of business, business and financial linkages, and common promoters
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Short Term Debt (Including Commercial Paper)  ST    --    --    --  14-08-18  Withdrawn 18-08-17  CRISIL A1+  CRISIL A1+ 
                    17-03-17  CRISIL A1+   
Fund-based Bank Facilities  LT/ST  715.00  CRISIL AA/Stable/ CRISIL A1+      01-11-19  CRISIL AA-/Positive/ CRISIL A1+  14-08-18  CRISIL AA-/Positive/ CRISIL A1+  18-08-17  CRISIL AA-/Stable/ CRISIL A1+  CRISIL AA-/Stable/ CRISIL A1+ 
                    17-03-17  CRISIL AA-/Stable/ CRISIL A1+   
Non Fund-based Bank Facilities  LT/ST  25.00  CRISIL A1+      01-11-19  CRISIL A1+  14-08-18  CRISIL A1+  18-08-17  CRISIL A1+  CRISIL A1+ 
                    17-03-17  CRISIL A1+   
All amounts are in Rs.Cr.
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Cash Credit .2 CRISIL AA/Stable Cash Credit .2 CRISIL AA-/Positive
Export Finance Limit^ 150 CRISIL A1+ Export Finance Limit^ 150 CRISIL A1+
Letter of credit & Bank Guarantee 25 CRISIL A1+ Letter of credit & Bank Guarantee 25 CRISIL A1+
Packing Credit## 159.8 CRISIL A1+ Packing Credit## 159.8 CRISIL A1+
Packing Credit@@ 150 CRISIL A1+ Packing Credit@@ 150 CRISIL A1+
Packing Credit 75 CRISIL A1+ Packing Credit 125 CRISIL A1+
Packing Credit* 180 CRISIL AA/Stable Packing Credit* 180 CRISIL AA-/Positive
Packing Credit 50 Withdrawn Proposed Working Capital Facility 28 CRISIL AA-/Positive
Proposed Working Capital Facility 28 Withdrawn -- 0 --
Total 818 -- Total 818 --
^100% interchangeability between letter of credit
##100% interchangeability between packing credit in foreign currency, foreign documentary bill purchase, and foreign usance discount bill purchase
*100% interchangeability between packing credit in foreign currency, foreign bill purchase, foreign bill discounting, foreign bill negotiation, bill purchase, bill discounting, working capital demand loan, and short-term loan
@@100% interchangeability between packing credit in foreign currency, import letter of credit, standby letter of credit, short-term loan, and overdraft export invoice financing.
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
CRISILs Criteria for Consolidation
CRISILs Criteria for rating short term debt

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Anuj Sethi
Senior Director - CRISIL Ratings
CRISIL Limited
D:+91 44 6656 3100
anuj.sethi@crisil.com


Sameer Charania
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8025
sameer.charania@crisil.com


Hari Rajai
Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 44 6656 3142
Hari.Rajai@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL